GSE128478
Identification of miR181ab1 targets in mutant Kras lung cancer cells
RNAseq comparison of miR181ab1-knockout and miR181ab1-reconstituted mouse lung cancer cells (KLA) Overall design: KLA cells derived from KrasLA2 ; miR181ab1f/f mice transduced with a control plasmid (mut/mut) or a plasmid expressing exogenous miR181ab1 (wt/wt) were treated with adenoviral Cre recombinase to deplete endogenous miR181ab1 expression